Hội chứng Zollinger-Ellison: Nhân một trường hợp lâm sàng hiếm gặp u gastrin tại gan
DOI:
https://doi.org/10.63583/gt6mph79Từ khóa:
Hội chứng Zollinger-Ellison; U gastrin; U đa tuyến nội tiết.Tóm tắt
Đặt vấn đề: Hội chứng Zollinger-Ellison (ZES) là một hội chứng gồm các triệu chứng trong bệnh cảnh trào ngược dạ dày, thực quản; bệnh loét dạ dày, tá tràng; tiêu chảy kéo dài và sút cân. ZES về bản chất rất khó chẩn đoán do các triệu chứng không đặc hiệu dẫn đến việc chẩn đoán chậm trễ. Chúng tôi báo cáo một trường hợp bệnh nhân nam 38 tuổi bị đau bụng, mắc chứng khó tiêu và tiêu chảy không rõ nguyên nhân kéo dài hơn 10 năm, đã thăm khám và điều trị tại nhiều cơ sở y tế mà không được chẩn đoán ZES, khiến việc điều trị không hiệu quả, gây ảnh hưởng nhiều đến chất lượng cuộc sống của người bệnh và tốn kém chi phí quản lý bệnh không cần thiết.
Tài liệu tham khảo
1. Epelboym I, Mazeh H. Zollinger-Ellison Syndrome: Classical Considerations and Current Controversies. Oncologist. 2014;19(1):44-50. http://doi.org/cxsp.
2. Shim YK, Kim N. Nonsteroidal anti-inflammatory drug and aspirin-induced peptic ulcer disease. Korean J Gastroenterol. 2016;67:300–312. https://doi.org/10.4166/kjg.2016.67.6.300
3. Graham DY. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol. 2014;20:5191–5204. https://doi.org/10.3748/wjg.v20.i18.5191
4. Banasch M, Schmitz F. Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors. Wien Klin Wochenschr. 2007;119:573–578. https://doi.org/10.1007/s00508-007-0884-2
5. Roy PK, Venzon DJ, Shojamanesh H, et al. Zollinger-Ellison syndrome: clinical presentation in 261 patients. Medicine. 2000;79:379–411. https://doi.org/10.1097/00005792-200011000-00004
6. Epelboym I, Mazeh H. Zollinger-Ellison Syndrome: Classical Considerations and Current Controversies. Oncologist. 2014;19(1):44-50. http://doi.org/cxsp.
7. Meko JB, Norton JA. Management of patients with Zollinger-Ellison syndrome. Annu Rev Med. 1995;46:395–411. https://doi.org/10.1146/annurev.med.46.1.395
8. Jensen RT. Gastrinomas: advances in diagnosis and management. Neuroendocrinology. 2004;80(Suppl 1):23–27.
9. Roy PK, Venzon DJ, Shojamanesh H, et al. Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore). 2000;79(6):379–411.
10. Norton JA. Gastrinoma: advances in localization and treatment. Surg Oncol Clin N Am. 1998;7(4):845–861.
11. Lenhart A, Hassan M, Meighani A, Sadiq O, Siddiqui Y. A Perplexing Case of Abdominal Pain That Led to the Diagnosis of Zollinger-Ellison Syndrome. Case Rep Gastrointest Med. 2017;2017:636952. http://doi.org/f9vq9c
12. Rindi G, Arnold R, Bosman FT. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. Trong: Bosman TF, Carneiro F, Hruban RH, Theise ND (biên tập). WHO Classification of Tumours of the Digestive System. Ấn bản lần thứ 4. Lyon: International Agency for Research on Cancer; 2010. tr. 13
13. Ito T, Igarashi H, Jensen RT. Zollinger–Ellison syndrome: recent advances and controversies. Curr Opin Gastroenterol. 2013;29(6):650–661. http://doi.org/cxsq
14. Berna MJ, Hoffmann KM, Long SH, Serrano J, Gibril F, Jensen RT. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients… Medicine (Baltimore). 2006;85(6):331–364. http://doi.org/bzhkdm
15. Ito T, Igarashi H, Jensen RT. Zollinger–Ellison syndrome: recent advances and controversies. Curr Opin Gastroenterol. 2013;29(6):650–661. http://doi.org/cxsq
16. Roy PK, Venzon DJ, Shojamanesh H, Abou-Saif A, Peghini P, Doppman JL, et al. Zollinger–Ellison syndrome: clinical presentation in 261 patients. Medicine (Baltimore). 2000;79(6):379–411. http://doi.org/cd3tzg
17. Ito T, Cadiot G, Jensen RT. Diagnosis of Zollinger–Ellison syndrome: Increasingly difficult. World J Gastroenterol. 2012;18(39):5495–5503. http://doi.org/cxsr
18. Berna MJ, Hoffmann KM, Long SH, Serrano J, Gibril F, Jensen RT. Serum gastrin in Zollinger–Ellison syndrome: II… Medicine (Baltimore). 2006;85(6):331–364. http://doi.org/bzhkdm
19. Imamura M, Nakamoto Y, Uose S, Komoto I, Awane M, Taki Y. Diagnosis of functioning pancreaticoduodenal neuroendocrine tumors. J Hepatobiliary Pancreat Sci. 2015;22:602–609.
20. Roy PK, Venzon DJ, Shojamanesh H, et al. Zollinger–Ellison syndrome: clinical presentation in 261 patients. Medicine. 2000;79:379–411. https://doi.org/10.1097/00005792-200011000-00004
21. Meko JB, Norton JA. Management of patients with Zollinger–Ellison syndrome. Annu Rev Med. 1995;46:395–411. https://doi.org/10.1146/annurev.med.46.1.395
22. Wilcox CM, Seay T, Arcury JT, Mohnen J, Hirschowitz BI. Zollinger-Ellison syndrome: presentation, response to therapy, and outcome. Dig Liver Dis. 2011;43:439–443. https://doi.org/10.1016/j.dld.2010.11.007
23. Metz DC. Diagnosis of the Zollinger-Ellison Syndrome. Clin Gastroenterol Hepatol. 2012;10(2):126–130. http://doi.org/fj7bjd
24. Braden B, Jenssen C, D’Onofrio M, Hocke M, Will U, Moller K, et al. B-mode and contrast-enhancement characteristics of small nonincidental neuroendocrine pancreatic tumors. Endosc Ultrasound. 2017;6(1):49–54. http://doi.org/f9q7x7
25. Mendelson AH, Donowitz M. Catching the zebra: clinical pearls and pitfalls for the successful diagnosis of Zollinger–Ellison syndrome. Dig Dis Sci. 2017;62:2258–2265. https://doi.org/10.1007/s10620-017-4695-7
26. Alexander HR, Fraker DL, Norton JA, Bartlett DL, Tio L, Benjamin SB, et al. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger–Ellison syndrome. Ann Surg. 1998;228:228–238.
27. Nehar D, Lombard-Bohas C, Olivieri S, et al. Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours. Clin Endocrinol (Oxf). 2004;60:644–652.
28. Smallfield GB, Allison J, Wilcox CM. Prospective evaluation of quality of life in patients with Zollinger–Ellison syndrome. Dig Dis Sci. 2010;55(11):3108–3112. http://doi.org/cfc76h
29. Rindi G, Arnold R, Bosman FT. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. Trong: Bosman TF, Carneiro F, Hruban RH, Theise ND (biên tập). WHO Classification of Tumours of the Digestive System. Ấn bản 4. Lyon: IARC; 2010. tr. 13
30. Ito T, Igarashi H, Jensen RT. Zollinger–Ellison syndrome: recent advances and controversies. Curr Opin Gastroenterol. 2013;29(6):650–661. http://doi.org/cxsq
31. De Herder WW, Lamberts SW. Clinical endocrinology and metabolism: Gut endocrine tumours. Best Pract Res Clin Endocrinol Metab. 2004;18:477–495.
32. Saclarides TJ. Gastrinoma. Trong: Common Surgical Diseases: An Algorithmic Approach to Problem Solving. Millikan KW, Saclarides TJ (eds). Springer; 1998. tr. 135–138.
33. Arnold R, Rinke A, Schmidt CH, Hofbauer L. Endocrine tumours of the gastrointestinal tract: Chemotherapy. Best Pract Res Clin Gastroenterol. 2005;19:649–656.
